What Questions Should I Ask a Neurologist About CADASIL?
At a Glance
Choosing a CADASIL neurologist is easier when you ask about experience with rare small-vessel disease, MRI and genetic test interpretation, stroke prevention and blood pressure control, migraine care, and collaboration with neurogenetics specialists.
In this answer
4 sections
Finding a neurologist who understands CADASIL (Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy) is an important step in managing your care. Because CADASIL is a rare disease, many general neurologists may only see a few cases in their career. You can evaluate a neurologist’s experience by asking targeted questions about their approach to blood pressure monitoring, stroke prevention, migraine management, and genetic test interpretation.
Understanding Your CADASIL Care Needs
CADASIL is a genetic disorder caused by mutations in the NOTCH3 gene, which leads to vessel-wall degeneration in small cerebral arteries and subsequent white-matter injury in the brain [1]. While there is no proven disease-modifying cure, care involves much more than just treating isolated symptoms. Comprehensive management includes addressing conventional vascular risks (like smoking, diabetes, and cholesterol), coordinating physical rehabilitation, and supporting cognitive and mood health [2][3].
Because of these complexities, a local neurologist can often manage your ongoing care, but consulting with a specialized neurogenetics center or a stroke neurologist with expertise in rare monogenic small-vessel diseases can be very helpful [4][1]. They can assist with uncertain genetic results, difficult medication decisions, and family counseling while coordinating with your local doctor.
Urgent Stroke Symptoms
Because CADASIL increases the risk of stroke, and migraine aura can sometimes overlap with stroke symptoms, you need a clear emergency plan. Seek emergency medical help immediately—do not wait for a specialist appointment—if you or a loved one experience:
- Sudden facial droop, weakness, or numbness
- Sudden trouble speaking or understanding speech
- Sudden vision loss or changes
- Severe, unexplained loss of balance or coordination
- A new, unusually severe headache
Questions to Ask a New Neurologist
1. “How do you evaluate and monitor CADASIL on an MRI?”
Why you should ask this: A doctor familiar with the condition will know that classic MRI findings include changes in the anterior temporal poles and external capsule, though these are not present in every patient [5]. They will also understand how to use susceptibility-sensitive MRI sequences to identify cerebral microbleeds (tiny areas of past bleeding in the brain) [6]. An experienced neurologist will interpret these scans in the context of your symptoms and history to guide individualized treatment, rather than relying on a rigid, fixed scanning schedule.
2. “How do you approach antiplatelet and anticoagulant medications for stroke prevention?”
Why you should ask this: CADASIL involves ischemic strokes (caused by damage or blockage in small brain arteries) as well as a risk for brain bleeds [4][7]. There is no universal daily antiplatelet (like aspirin) regimen for asymptomatic CADASIL patients. Furthermore, anticoagulants (stronger blood thinners used for other conditions like atrial fibrillation) carry different bleeding profiles. An experienced neurologist will carefully weigh the potential benefits of these medications against your personal microbleed burden and overall health [8][6]. You should never start or stop these medications without consulting your doctor.
3. “What is my individualized blood pressure target?”
Why you should ask this: Careful blood pressure control is a cornerstone of CADASIL management [2]. High blood pressure is strongly associated with an increased risk of intracerebral hemorrhage, and some observational studies suggest this risk may be especially relevant for patients with specific NOTCH3 variants, such as the R544C mutation [7][9]. However, there is no single “CADASIL-specific” blood pressure number. Your doctor should set an individualized target based on standard hypertension guidelines, your kidney and cardiovascular health, and your specific symptoms [4].
4. “How will we weigh the risks and benefits of migraine treatments?”
Why you should ask this: Migraines, often with aura, are a common feature of CADASIL [1]. Standard treatments often include triptans or other vasoconstrictive medications (drugs that narrow blood vessels). Because CADASIL affects brain blood vessels, the use of triptans requires a careful, individualized risk-benefit discussion; they are not universally banned, but caution is advised [10]. Alternatives, such as CGRP inhibitors, have shown promise in small case reports, but they also lack robust, long-term safety data in CADASIL [11]. An experienced specialist will discuss these uncertainties and help you build a personalized migraine plan.
The Role of Genetic Counseling
If you have questions about your genetic test results, a neurogenetics center can be invaluable. For instance, they can help interpret a Variant of Uncertain Significance (VUS). A VUS means a genetic change was found, but it is not definitively clear if it causes the disease. A VUS should not be used as proof of CADASIL or to make medical decisions on its own [12].
Furthermore, if a clearly pathogenic (disease-causing) NOTCH3 mutation is confirmed, genetic counselors can discuss cascade testing for your adult relatives [13]. Because CADASIL is inherited in an autosomal dominant pattern, each child of an affected parent has a 50% chance of inheriting the mutation, though symptoms and onset age can vary [14]. Counseling ensures families understand the medical, emotional, and insurance implications before making family-testing decisions.
Common questions in this guide
What can I ask to judge a neurologist’s experience with CADASIL?
What should an experienced CADASIL neurologist look for on an MRI?
Does everyone with CADASIL need aspirin or another blood thinner?
How is a safe blood pressure goal chosen for someone with CADASIL?
Are migraine medicines such as triptans safe with CADASIL?
When should I see a neurogenetics center or genetic counselor?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How many patients with CADASIL or other monogenic small-vessel diseases have you managed, and how do you stay current on care guidelines?
- 2.Under what specific circumstances would you recommend an antiplatelet, an anticoagulant, or neither, given my MRI results?
- 3.What is my individualized blood pressure goal, and how will we monitor it?
- 4.How do you evaluate the risks and benefits of triptans versus CGRP inhibitors for my migraines?
- 5.What conventional vascular risks—such as cholesterol or diabetes—should we be prioritizing in my care plan?
- 6.When would it be helpful for me to consult a specialized neurogenetics center or a genetic counselor?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
Related questions
References
References (14)
- 1
Management of Inherited CNS Small Vessel Diseases: The CADASIL Example: A Scientific Statement From the American Heart Association.
Meschia JF, Worrall BB, Elahi FM, et al.
Stroke 2023; (54(10)):e452-e464 doi:10.1161/STR.0000000000000444.
PMID: 37602377 - 2
Predictors of Clinical Worsening in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy: Prospective Cohort Study.
Chabriat H, Hervé D, Duering M, et al.
Stroke 2016; (47(1)):4-11 doi:10.1161/STROKEAHA.115.010696.
PMID: 26578659 - 3
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy (CADASIL): A Rare Cause of Transient Ischemic Attack.
Ashraf S, Allena N, Shrestha E, et al.
Cureus 2022; (14(10)):e30940 doi:10.7759/cureus.30940.
PMID: 36465750 - 4
Monogenic cerebral small-vessel diseases: diagnosis and therapy. Consensus recommendations of the European Academy of Neurology.
Mancuso M, Arnold M, Bersano A, et al.
European journal of neurology 2020; (27(6)):909-927 doi:10.1111/ene.14183.
PMID: 32196841 - 5
CADASIL: Imaging Characteristics and Clinical Correlation.
Zhu S, Nahas SJ
Current pain and headache reports 2016; (20(10)):57 doi:10.1007/s11916-016-0584-6.
PMID: 27591799 - 6
Cerebral Microbleed Burdens in Specific Brain Regions Are Associated With Disease Severity of Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy.
Chung CP, Chen JW, Chang FC, et al.
Journal of the American Heart Association 2020; (9(13)):e016233 doi:10.1161/JAHA.120.016233.
PMID: 32552418 - 7
Intracerebral Hemorrhage in Patients With CADASIL: Additive Impact of the NOTCH3 R544C Variant and Hypertension?
Chen CH, Cheng YW, Zhang R, et al.
Stroke 2025; (56(8)):2159-2166 doi:10.1161/STROKEAHA.124.050484.
PMID: 40270244 - 8
R558C NOTCH3 Mutation in a CADASIL Patient with Intracerebral Hemorrhage: A Case Report with Literature Review.
Hu L, Liu G, Fan Y
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2022; (31(7)):106541 doi:10.1016/j.jstrokecerebrovasdis.2022.106541.
PMID: 35523050 - 9
Pro-Hemorrhagic Cerebral Autosomal Dominant Arteriopathy with Subcortical Infarcts and Leukoencephalopathy Associated with NOTCH3 p.R75P Mutation with Low Vascular NOTCH3 Aggregation Property.
Ishiyama H, Kim H, Saito S, et al.
Annals of neurology 2024; (95(6)):1040-1054 doi:10.1002/ana.26916.
PMID: 38520151 - 10
Long-Term Treatment with the Calcitonin Gene-Related Peptide Receptor Antagonist Erenumab in CADASIL: Two Case Reports.
Albanese M, Pescini F, Di Bonaventura C, et al.
Journal of clinical medicine 2024; (13(7)) doi:10.3390/jcm13071870.
PMID: 38610637 - 11
Genetic migraine disorders and the response to calcitonin gene-related peptide antagonist treatment.
Kuczynski AM, Kingston WS
Headache 2025; (65(6)):1041-1043 doi:10.1111/head.14942.
PMID: 40341526 - 12
CADASIL or NOTCH3 mutaion spectrum diseases? Interpretation of NOTCH3 mutations and clinical heterogeneity in CADASIL.
Wang Y, Liu Y, Mo H, et al.
Frontiers in neurology 2025; (16()):1662012 doi:10.3389/fneur.2025.1662012.
PMID: 41018180 - 13
Genetic diagnosis of CADASIL in three Hong Kong Chinese patients: A novel mutation within the intracellular domain of NOTCH3.
Hung LY, Ling TK, Lau NKC, et al.
Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia 2018; (56()):95-100 doi:10.1016/j.jocn.2018.06.050.
PMID: 29980472 - 14
Hereditary Cerebral Small Vessel Diseases and Stroke: A Guide for Diagnosis and Management.
Guey S, Lesnik Oberstein SAJ, Tournier-Lasserve E, Chabriat H
Stroke 2021; (52(9)):3025-3032 doi:10.1161/STROKEAHA.121.032620.
PMID: 34399586
This page provides general information about choosing a neurologist for CADASIL and does not replace medical advice. Discuss your MRI findings, medications, blood pressure goals, migraine treatment, and genetic results with your healthcare team.
Get notified when new evidence is published on Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.